G

Guangdong Biolight Meditech Co Ltd
SZSE:300246

Watchlist Manager
Guangdong Biolight Meditech Co Ltd
SZSE:300246
Watchlist
Price: 16.39 CNY -1.09% Market Closed
Market Cap: ¥4.3B

Guangdong Biolight Meditech Co Ltd
Accrued Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Guangdong Biolight Meditech Co Ltd
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
G
Guangdong Biolight Meditech Co Ltd
SZSE:300246
Accrued Liabilities
¥13.2m
CAGR 3-Years
0%
CAGR 5-Years
-10%
CAGR 10-Years
14%
A
APT Medical Inc
SSE:688617
Accrued Liabilities
¥197.2m
CAGR 3-Years
26%
CAGR 5-Years
33%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Accrued Liabilities
¥348.1m
CAGR 3-Years
41%
CAGR 5-Years
40%
CAGR 10-Years
31%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Accrued Liabilities
¥2.7B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Andon Health Co Ltd
SZSE:002432
Accrued Liabilities
¥56.6m
CAGR 3-Years
21%
CAGR 5-Years
15%
CAGR 10-Years
12%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Accrued Liabilities
¥922.4m
CAGR 3-Years
17%
CAGR 5-Years
31%
CAGR 10-Years
N/A
No Stocks Found

Guangdong Biolight Meditech Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Health Care

Guangdong Biolight Meditech Co., Ltd. engages in the research, development, production, sale, and service of medical device products. The company is headquartered in Zhuhai, Guangdong and currently employs 1,335 full-time employees. The company went IPO on 2011-07-19. Its medical monitoring equipment includes monitoring equipment, electrocardiograph, pulse oximeters and central monitoring systems. Its hemodialysis products include hemodialysis machines, hemodialyzers, hemodialysis powders/dialysates and perfusion machines. The firm distributes its products in domestic and overseas markets.

Intrinsic Value
11.69 CNY
Overvaluation 29%
Intrinsic Value
Price ¥16.39
G

See Also

What is Guangdong Biolight Meditech Co Ltd's Accrued Liabilities?
Accrued Liabilities
13.2m CNY

Based on the financial report for Sep 30, 2025, Guangdong Biolight Meditech Co Ltd's Accrued Liabilities amounts to 13.2m CNY.

What is Guangdong Biolight Meditech Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
14%

Over the last year, the Accrued Liabilities growth was -4%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett